Histidine-rich glycoprotein binding to T-cell lines and its effect on T-cell substratum adhesion is strongly potentiated by zinc

Immunology

Volumn 88, Issue 2, 1996, Pages 198-206

  Olsen, H M ^a   Parish, C R ^a   Altin, J G ^a  

^a Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COPPER; FIBRONECTIN; HISTIDINE; LAMININ; ZINC;

ARTICLE; CELL MEMBRANE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOREGULATION; LEUKEMIA CELL LINE; LEUKOCYTE ADHERENCE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; T LYMPHOCYTE ACTIVATION;

BLOOD PROTEINS; CELL ADHESION; CELL LINE; CLONE CELLS; DRUG SYNERGISM; FLOW CYTOMETRY; HUMANS; PROTEIN BINDING; PROTEINS; T-LYMPHOCYTES; ZINC;

EID: 0030014587     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.1996.tb00005.x     Document Type: Article

References (26)

1. 2-glykoproteins (Cm-Protein I). Hoppe-Seyler's Z Physiol Chem 353, 1133.
2. RYLATT D.B., SIA D.Y., MUNDY J.P. & PARISH C.R. (1981) Autorosette inhibition factor: isolation and properties of the human plasma protein. Eur J Biochem 119, 641.
3. SIA D.Y., RYLATT D.B. & PARISH C.R. (1982) Anti-self receptors. V. Properties of a mouse serum factor that blocks autorosetting receptors on lymphocytes. Immunology 45, 207.
4. LIJNEN H.R., RYLATT D.B. & COLLEN D. (1983) Physicochemical, immunochemical and functional comparison of human histidine-rich glycoprotein and autorosette inhibition factor. Biochim Biophys Acta 742, 109.
5. BROWN K.J. & PARISH C.R. (1994) Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor. Biochem 33, 13918.
6. LIJNEN H.R., HOYLAERTS, M. & COLLEN D. (1980) Isolation and characterisation of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein. J Biol Chem 255, 10214.
7. LIJNEN H.R., HOYLAERTS M. & COLLEN D. (1983) Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma. J Biol Chem 258, 3803.
8. LIJNEN H.R., VAN HOEF B. & COLLEN D. (1984) Histidine-rich glycoprotein modulates the anticoagulant activity of heparin in human plasma. Thromb Haemostas 51, 266.
9. LEUNG L.L.K. (1986) Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J Clin Invest 77, 1305.
10. PETERSON C.B., MORGAN W.T. & BLACKBURN M.J. (1987) Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin. Evidence for a mechanism involving competition with both antithrombin and thrombin for heparin binding. J Biol Chem 262, 7567.
11. LEUNG L. (1993) Histidine-rich glycoprotein: an abundant plasma protein in search of a function. J Lab Clin Med 121, 630.
12. ANGLES-CANO E., GRIS J.C., LOYAU S. & SCHVED J.F. (1993) Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism. J Lab Clin Med 121, 646.
13. HENNIS B,C., VAN BOHEEMEN P.A., KOELEMAN B.P.C. et al. (1995) A specific allele of the histidine-rich glycoprotein (HRG) locus is linked with elevated plasma levels of HRG in a Dutch family with thrombosis. Br J Haemat 89, 845.
14. SHIGEKIYO T., KANAZUKA H., AZUMA H., OSHIMA T., KUSAKA K. & SAITO S. (1995) Congenital deficiency of histidine-rich glycoprotein: failure to identify abnormalities in routine laboratory assays of hemostatic function, immunologic function and trace elements. J Lab Clin Med 125, 719.
15. CHANG N.-S., LEU R.W., RUMMAGE J.A., ANDERSON J.K. & MOLE J.E. (1992) Regulation of complement functional efficiency by histidine-rich glycoprotein. Blood 79, 2973.
16. CHANG N.-S., LEU R.W., RUMMAGE J.A., ANDERSON J.K. & MOLE J.E. (1992) Regulation of macrophage Fc receptor expression and phagocytosis by histidine-rich glycoprotein. Immunology 77, 532.
17. CHANG N.-S., LEU R.W., ANDERSON J.K. & MOLE J.E. (1994) Role of N-terminal domain of histidine-rich glycoprotein in modulation of macrophage Fcy receptor-mediated phagocytosis. Immunology 81, 296.
18. SHATSKY M., SAIGO K., BURDACH S., LEUNG L.L.K. & LEVITT L.J. (1989) Histidine-rich glycoprotein blocks T cell rosette formation and modulates both T cell activation and immunoregulation. J Biol Chem 264, 8254.
19. SAIGO K., SHATSKY M., LEVITT L.J. & LEUNG L.L.K. (1989) Interaction of histidine-rich glycoprotein with human T lymphocytes. J Biol Chem 264, 8249.
20. LAMB-WHARTON R.J. & MORGAN W.T. (1993) Induction of T-lymphocyte adhesion by histidine-proline-rich glycoprotein and Concanavalin A. Cell Immunol 152, 544.
21. MORGAN W.T. (1981) Interactions of the histidine-rich glycoprotein of serum with metals. Biochem 20, 1054.
22. MORGAN W.T. (1985) The histidine-rich glycoprotein of serum has a domain rich in histidine, proline, and glycine that binds heme and metals. Biochem 24, 1496.
23. KAZAMA K. & KOIDE T. (1992) Modulation of protein C inhibitor activity by histidine-rich glycoprotein and platelet factor 4: role of zinc and calcium ions in the heparin-neutralising ability of histidine-rich glycoprotein. Thromb Haemostas 67, 50.
24. ALTIN J.G., PAGLER E.B. & PARISH C.R. (1994) Evidence for an association of CD45 with 32000 33000 MW phosphoproteins on murine T and B lymphocytes. Immunology 83, 420.
25. KOIDE T., FOSTER D., YOSITAKE S. & DAVIE E.W. (1986) Amino acid sequence of human histidine-rich glycoprotein derived from the nucleotide sequence of its cDNA. Biochem 25, 2220.
26. SMITH A., NUIRY I. & MORGAN W.T. (1985) Proteolysis of histidine-rich glycoprotein in plasma and in patients undergoing thrombolytic therapy. Thrombosis Res 40, 653.